Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Remdesivir for Potential Treatment of Covid-19

Drug Name

Remdesivir

Developer

Gilead Sciences

Therapy Class

Antiviral agent

Product Description

Nuc inhibitor

Indications

Potential treatment of COVID-19, and Ebola virus infection

Market Sector

Anti-infectious diseases

Current Development Status

Under investigation
Expand
Close
Close
Close

Go Top